MYOS | tickerfilter.com

Fundamental analysis

13%

Profitability 0%

Dept financing 13%

Liquidity 75%

Performance 10%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

0 0%

1 Month

0 0%

3 Months

0 0%

6 Months

0 0%

1 Year

0 0%

2 Year

0 0%

Key data

Stock price

$1.37

P/E Ratio

N/A

DAY RANGE

$1.01 - $1.01

EPS

-$0.35

52 WEEK RANGE

$0.74 - $3.85

52 WEEK CHANGE

-$31.76

MARKET CAP

12.314 M

YIELD

N/A

SHARES OUTSTANDING

12.192 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.00

PUBLIC FLOAT

$6,519,870

AVERAGE 10 VOLUME

$124,488

AVERAGE 30 VOLUME

$130,195

Company detail

CEO: Joseph Manello
Region: US
Website: http://www.myosrens.com
Employees: 15
IPO year: -

Issue type: Common Stock
Market: NASDAQ
Industry: Medical Specialties
Sector: Health Technology

MYOS RENS Technology, Inc. operates as a nutrition company, develops and markets products that improve muscle health and performance. Its primary product is Fortetropin, a proprietary bioactive composition derived from fertilized egg yolk, intended to increase lean muscle mass, size, and strength. The company was founded on April 11, 2007 and is headquartered in Cedar Knolls, NJ.

MYOS - MYOS RENS Technology Inc.